Skip to content

vTv Therapeutics Inc.

VTVT

CIK 0001641489

← back to feed
Revenue (TTM)
$36.84M
−100.0% YoY Q1 Mar 2026
Net Income (TTM)
$4.3M
−46.1% YoY Q1 Mar 2026
EPS Diluted (TTM)
—
Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
-4.5%
Q1 Mar 2026
Net Margin
11.7%
Q1 Mar 2026
Free Cash Flow (TTM)
−$9.03M
Q1 Mar 2026
Cash
$98.09M
Q1 Mar 2026
Total Debt
$2.37M
Q1 Mar 2026
Shares Outstanding
0 sh
Q1 Mar 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings